New COVID-19 Vaccine Approved for 12 to 17-year-olds

UK’s approval of Moderna COVID-19 vaccine for 12- to 17-year-olds comes after the safety checks from the Medicines and Healthcare products Regulatory Agency (MHRA).

The UK's health regulator has approved Moderna's COVID-19 vaccine for use in children aged 12 to 17 years. This happened weeks after Pfizer's shot was given the green light for deployment ahead of schools reopening.

The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed the COVID-19 vaccine known as Spikevax, which is safe and effective in this age group.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘The UK regulator approves Spikevax COVID-19 vaccine for 12 to 17-year-olds.’

Though children develop mild or no symptoms with COVID-19, they are still able to spread the virus and some remain at risk of becoming seriously ill.

Moderna's vaccine was recommended for use in adolescents by European regulators in July and is awaiting U.S. authorization. It is already approved for people over the age of 18 in the UK.

Britain's Joint Committee on Vaccination and Immunisation (JCVI) gave the approval ahead for 16 and 17-year-olds to get their first dose of Pfizer's COVID-19 vaccine ahead of the reopening of schools for the new education year in September.

COVID in Children | Guidelines for Management of COVID-19 in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.

JCVI will make a decision on whether 12–17-year olds should be vaccinated with the shot made by Moderna as part of its deployment programme.

The MHRA said it did not identify any new side effects with the vaccine and the safety data was comparable with that for young adults, with adverse events being mostly mild and moderate and including sore arms or fatigue.

Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.

UK joins the likes of the United States, Israel, France and a number of other nations who are already inoculating young people against coronavirus.

COVID Vaccination for Pregnant Women
The Indian Government has approved Covid-19 vaccination of pregnant women, who are to be counselled and informed regarding the risks and benefits of the vaccines.

Source-Medindia